Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ocata Therapeutics Inc (NASDAQ:OCAT)

During the Trading Day
4.68 +0.08 / +1.74%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.70 +0.01 / +0.21%
Volume: 1.3K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 3
Quarter 4
Quarter 1
Quarter 2
Revenue and IncomeNet Revenues39.5K39.5K39.5K39.5K
Cost of Goods Sold15.6K15.6K15.6K15.6K
Depreciation And Amortization45.0K63.7K65.1K67.7K
Operating ExpensesGross Income-21.2K-39.8K-41.3K-43.8K
General Expenses4.0M6.8M7.0M6.6M
Research And Development2.4M2.9M3.4M3.5M
Total Operating Expenses4.0M6.9M7.1M6.7M
Non-Operating ExpensesOperating Income-4.0M-6.8M-7.0M-6.7M
Extraordinary Credit263.8K25.0K6.0K337.7K
Interest Expense On Debt69.000.000.00437.00
Other Expenses0.00-10.9K0.00-904.2K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.7M-6.8M-7.0M-7.2M
Preferred Dividend-672.2K0.000.000.00
Net Income-3.7M-6.8M-7.0M-7.2M
Shares To Calculate EPSShares To Calculate EPS33.6M34.6M34.9M36.6M
Shares To Calculate EPS Diluted33.6M34.6M34.9M36.6M
Earnings Per ShareEPS-$0.13-$0.20-$0.20-$0.20
EPS Diluted-$0.13-$0.20-$0.20-$0.20